Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health‐related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension-Reference-Cited by-同舟云学术

Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health‐related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension

Published:2016-11-21 Issue:1 Volume:19 Page:116-125
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Liu Licette C.Y.¹,Hummel Yoran M.¹,van der Meer Peter¹,Berger Rolf M.F.²,Damman Kevin¹,van Veldhuisen Dirk J.¹,Voors Adriaan A.¹,Hoendermis Elke S.¹

Affiliation:

1. Department of Cardiology, University of Groningen University Medical Centre Groningen Hanzeplein 1 9713 GZ Groningen the Netherlands

2. Department of Pediatric and Congenital Cardiology, University of Groningen University Medical Centre Groningen Groningen the Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.662

Reference47 articles.

1. Increased pulmonary vascular resistance, right ventricular dysfunction, and reversible pulmonary vasoconstriction in type 2 pulmonary hypertension: who has it and are we missing a potential therapeutic target in patients with heart failure?

2. The pathophysiology of heart failure with preserved ejection fraction

3. Heart Failure With Preserved Ejection Fraction

4. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

5. Right heart dysfunction in heart failure with preserved ejection fraction

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibidores de la fosfodiesterasa 5 para el tratamiento de la insuficiencia cardiaca: revisión sistemática y metaanálisis de ensayos clínicos aleatorizados;Archivos de Cardiología de México;2024-07-17

2. PDE5 inhibition mitigates heart failure in hyperlipidemia;Biomedicine & Pharmacotherapy;2024-06

3. Exploring the therapeutic potential of tetrahydrobiopterin for heart failure with preserved ejection fraction: A path forward;Life Sciences;2024-05

4. Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction;Current Hypertension Reports;2024-04-01

5. PPARγ Agonist Pioglitazone Prevents Hypoxia-induced Cardiac Dysfunction by Reprogramming Glucose Metabolism;International Journal of Biological Sciences;2024